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Abstract
We examined the transcriptional augmentation of matrin 3, a nuclear matrix protein, of the SV40 promoter-
mediated luciferase gene (pGL3) following transient transfection of recombinant plasmids into cells. It has been
reported that the interaction of the Xmn I fragment, a highly repetitive DNA component as one of a typical matrix- or
scaffold-attachment regions (MAR/SAR) tethered upstream from the SV40 promoter (pGL3-Xmn I) with matrin 3
appeared to be required for augmentation of luciferase gene transcription. In this study, we investigated the levels of
induction in cells overexpressing the wild type and several deletion mutants of matrin 3. It appeared that pGL3-Xmn I
augmented luciferase production to 4-times the control level in Ac2F cells, but 23-fold in cells overexpressing matrin
3. Electrophoretic mobility shift assay showed that the Xmn I fragment augmented luciferase gene transcription
through interaction with matrin 3. Furthermore, our findings suggest that all of the functional domains tested in matrin
3 were necessary for transcriptional augmentation. We aim not only to describe the transcriptional augmentation of
matrin 3 with MAR/SAR, but also to strengthen interest in their use to mediate the expression of therapeutic
transgenes.
Keywords: Matrin 3; Nuclear matrix; Matrix attachment regions;
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Introduction
The nuclear matrix or scaffold was initially identified as a structural
framework of nuclear proteins that can be represented by fibrous
structures extending from the entire surface of denatured
chromosomes [1]. DNA segments to which matrix or scaffold proteins
can bind are termed matrix- or scaffold-attachment regions (MAR/
SAR). Structural analyses of the nucleus and chromosomes assigned a
significant role of MAR/SAR to the matrix or scaffold-mediated
stabilization of chromosomal structure. In the interphase cell nucleus,
chromatin is arranged in spatially separate, chromosome-specific
territories, which are maintained intact on the nuclear matrix as a
three-dimensional organization of the chromosomes [2]. The
organized structure of chromosomes is likely modulated in association
with transcription, replication, RNA splicing, and the cell-division
cycle, although mechanisms for the preferential alterations in
chromosomal structure are as yet largely unknown.
Several MAR/SAR binding proteins have been identified. In our
previous work, a 4.6-kb long P130 cDNA (AB205483) was cloned to
determine the molecular properties of P130 [3]. P130, comprising 845
amino acid residues and having molecular mass of 95.3 kDa, was
identical in structure to rat matrin 3 (BC062231) as revised from that
published by Belgrader et al. [4], and highly similar to human and
mouse matrin 3 (BC015031 and BC090833, respectively). Matrin 3 has
several functionally confirmed motifs such as a nuclear export signal
(NES), a nuclear localization signal (NLS), C2H2-type zinc-finger
motifs (ZF1 and ZF2), RNA-binding domains (RB1 and RB2) and a
membrane retention signal (MRS).
In vitro DNA-binding assays performed by us suggested several
unique properties of matrin 3. It bound to a highly repetitive DNA
component, an Xmn I fragment, which was also cloned from DNA
contained in rat liver nuclear scaffold [5]. In addition to binding to the
Xmn I fragment, matrin 3 bound to various MAR/SAR segments by
recognizing an ATATAT sequence, which causes base-unpairing [6,7],
as a binding site. Functionally, transient expression of reporter
luciferase gene constructs, in which Xmn I or distinct MAR/SAR
fragments were tethered upstream from the SV40 promoter of the
pGL3 promoter vector, increased luciferase gene transcription in
various types of recipient cells [7]. Bent and AT-rich regions of Xmn I
and MAR/SAR fragments appeared to be required for this increased
transcription. Southwestern blot analysis revealed that an Xmn I probe
bound to a 130-kDa polypeptide in a nuclear extract from Ac2F cells,
suggests that the binding of P130 as matrin 3 to an appropriate
sequence positioned near the promoter of a gene likely modulates
transcriptional activity.
In the present study, using several deletion mutants of matrin 3
expressed in Ac2F cells, we examined the levels of induction in cells
overexpressing the wild type with the aim of determining which
domain in matrin 3 is necessary for reporter luciferase transcriptional




The rat hepatoma cell line Ac2F was provided by the Japanese
Cancer Research resource and maintained in monolayer culture with
minimum essential medium (MEM) containing 10% fetal bovine
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serum and 0.006% kanamycin under 5% CO2 and 95% air at 37°C.
Culture media (Life Technologies, Carlsbad, CA, USA) and all other
materials were purchased through local distributors.
Plasmids carrying the Xmn I fragment and wild-type or
deletion mutants of matrin 3
Promoter vector pGL3 (Promega Corp, Madison, WI, USA) was
used to determine the extent of augmentation of SV40 promoter-
mediated luciferase gene transcription by the Xmn I fragment tethered
up-stream from the tract encompassing the SV40 promoter and the
firefly luciferase gene [7].
cDNA encoding wild-type or deletion mutants of matrin 3 were
prepared by ligating the PCR-amplified product and subcloning into
pcDNA [3]. Plasmid DNA was propagated in E. coli DH5α and the
final preparation was obtained by CsCl equilibrium centrifugation.
Nucleotide sequences of DNA constructs tested were confirmed.
Transfection and expression in stable transfectants
Matrin 3 and its deletion mutants were expressed in stable
transfectants generated from Ac2F cells by electroporation of the
recombinant plasmids. These cells were incubated and maintained in
MEM at 37°C under 5% CO2 and 95% air containing G418 (400 µg/
ml).
Determination of the extent of augmentation of
transcription
Lipofection of the recombinant pGL3 and pRL-SV40 with
Transfectam (Promega Corp) into cells subcultured in dishes with a
diameter of 60 mm, preparation of cell lysate, and determination of
luciferase activity using a dual luciferase assay kit on a TopCount
(Packard Instrument Co., Inc., Meriden, CT, USA) were performed
according to the supplier’s instructions. The extent of augmentation of
transcription was determined as luciferase activity exhibited by cells
that received wild type pGL3 promoter vector and pRL-SV40 [7].
Preparation of the 32P-labeled Xmn I fragment and
electrophoretic mobility shift assay (EMSA)
The 370-bp Xmn I fragments were labeled with [32P]dCTP
(Bresatec) in a T4 DNA polymerase labeling system (Life
Technologies), according to the methods described in instruction
manuals from the suppliers [8]. The resulting 32P-labeled DNA was
designated as the [32P] Xmn I fragment. EMSA was performed using
the [32P] Xmn I fragment with nuclear extract in a final volume of 25
µl of reaction mixture containing 10 mM Tris-HCl (pH 7.4), 40 mM
NaCl, 1 mM EDTA, 4% glycerol, and 1 mM 2-mercaptoethanol.
Nuclear extracts were prepared from Ac2F and Ac2F highly expressing
matrin 3 [3]. In brief, all the mixtures were incubated at room
temperature for 30 min. The incubated mixtures were directly
electrophoresed on a slab gel [4% polyacrylamide, 7.6 mM Tris-HCl
(pH 7.9), 3.3 mM sodium acetate, 1 mM EDTA] at 4°C for 2.5 h at 200
V and subjected to an autoradiographic assay. The [32P] Xmn I
fragment complexes were quantified using a BAS2000 imaging
analyzer (Fujifilm,Tokyo, Japan).
Western blot analysis
Whole cell extracts were homogenized in SDS sample buffer
containing 125 mM Tris-HCl (pH 6.8), 4% SDS, 10% sucrose, 0.01%
bromophenol blue, and 10% 2-mercaptoethanol and boiled for 1 min.
Protein concentration was quantified by using the Bradford method
(Protein Assay Reagent Kit, Bio-Rad Laboratories, Inc., Hercules, CA,
USA). The samples were separated by SDS-polyacrylamide gel
electrophoresis, transferred onto nitrocellulose membrane (GE
Healthcare, Uppsala, Sweden) through a semidry-type blotting (Bio-
Rad Laboratories) method, blocked by 5% nonfat dry milk in PBS with
Tween-20 (PBS-T) (137 mM NaCl, 8.10 mM Na2HPO4, 2.68 mM KCl,
1.47 mM KH2PO4, 0.1% Tween-20), and incubated with appropriate
antibodies as described below. The filters were incubated with each
primary antibody for overnight at 4°C, with the corresponding
horseradish peroxidase (HRP)-conjugated secondary antibody for 1 h
at room temperature in 5% nonfat dry milk/PBS-T. Finally, the target
molecules were visualized through an enhanced chemiluminescence
Western blotting detection system (GE Healthcare) on the X-ray film
(GE Healthcare). The following primary and secondary antibodies
used in this study were anti-matrin 3 (Santa Cruz Biotechnology, Santa
Cruz, CA, USA), anti-β-actin (Sigma-Aldrich, St. Louis, MO, USA),
and anti-IgG HRP antibodies (GE Healthcare). Immunoblotted bands
were quantified using the Image Gauge (Fujifilm) after densitometric
scanning of the films.
Results
Requirement of matrin 3 for augmentation of gene
expression by Xmn I fragment
Figure 1A shows levels of luciferase induction during 24-h
incubation in 2 types of cell following transient transfection of
recombinant pGL3 plasmids carrying the Xmn I fragment. In Ac2F
cells, pGL3-Xmn I augmented production of luciferase to
approximately 5 times the control level. In Ac2F cells overexpressing
matrin 3, pGL3 augmented production of luciferase up to
approximately twice the control level and pGL3 Xmn I augmented
production of luciferase to approximately 23 times the control level.
Figure 1B shows that 130 and 123 kDa polypeptides detected by anti-
rat matrin 3 antibodies were expressed approximately 3–fold over the
control in stable transfectants generated from Ac2F cells. In this
context, given that matrin 3 is a phosphoprotein, the 130 and 123 kDa
polypeptides were presumed to be isoforms of matrin 3 [9].
EMSA using the Xmn I fragment and nuclear extracts from
wild matrin 3 highly expressed in Ac2F cells
To determine whether matrin 3 actually binds to the Xmn I
fragment, EMSA was performed using nuclear extracts from Ac2F
cells and Ac2F cells highly expressing matrin 3, and further using anti-
rat matrin 3 antibody. The Xmn I fragment incubated with either
control or matrin 3-highly expressing nuclear extract clearly retarded
the signals (Figure 2, lanes 2 and 6) using electrophoretic conditions
under which the Xmn I fragment alone migrates to near the bottom of
a gel (lane 1). All of the radioactive signals shifted further following
treatment of the reaction mixtures with anti-rat matrin 3 antibody
(lanes 3–5 and 7–9), confirming that the retarded signals correctly
reflect the DNA-binding properties of matrin 3. In contrast, anti-rat
matrin 3 antibody showed no DNA binding activity (lane 10).
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Figure 1: Induction of luciferase by transient transfection of
recombinant plasmids with Xmn I fragment. (A) parental Ac2F
cells or Ac2F cells overexpressing matrin 3 that received pGL3 and
pGL3–Xmn I were cultured for 24 h and their lysates were
prepared. Luciferase activities in Ac2F cells receiving pGL3 (relative
to pGL3) are expressed as the mean value of 3 experiments ± SD.
(B) Western blot analysis using anti-matrin 3 and β-actin
antibodies were performed with whole cell extracts (200 µg protein)
from parental Ac2F that received pGL3 and pGL3–Xmn I or Ac2F
cells of matrin 3-stable transfectants generated from recombinant
plasmids that received pGL3 (pGL3/matrin 3) and pGL3–Xmn I
(pGL3–Xmn I/matrin 3). Filled and open arrowheads indicate 130
and 123 kDa protein, respectively. Size of marker proteins is
indicated along the left ordinate.
Figure 2: EMSA using [32P] Xmn I fragments. Xmn I fragments
alone (lanes 1 and 10 with 3 µg anti-matrin 3 antibody) or Xmn I
fragments incubated with nuclear extracts (20 µg protein) from
parental Ac2F (lanes 2–5 with 0, 1, 2 and 3 µg anti-matrin 3
antibody) or Ac2F cells of matrin 3-stable transfectants (lanes 6-9
with 0, 1, 2 and 3 µg anti-matrin 3 antibody) are resolved by PAGE
followed by autoradiography. Filled and open arrowheads indicate
supershift attempted with nuclear extract/anti-matrin 3 antibody
and nuclear extract, respectively. Arrow indicates Xmn I fragments.
Requirement of functional domain in matrin 3 for the
augmentation of transcription
Matrin 3 has several functionally confirmed motifs including NLS,
NES, ZF1, ZF2, RB1, RB2, and MRS. To address the functional role of
each motif in transcriptional activity, transient transfections with SV40
promoter-mediated luciferase gene with the Xmn I fragment were
performed in Ac2F cells in which several deletion mutants of matrin 3
were overexpressed. Matrin 3 and its mutant proteins were expressed
approximately 2-3 fold over the control in stable transfectants
generated from Ac2F cells (data not shown). Figure 3 shows that
pGL3-Xmn I augmented production of luciferase to approximately 4
times the control level in parental Ac2F cells, as described in Figure 1.
Furthermore, in Ac2F cells overexpressing matrin 3, pGL3 augmented
production of luciferase to approximately 2.5 times the control level
and pGL3-Xmn I augmented production of luciferase to
approximately 20 times the control level. Matrin 3 mutants devoid of
ZF1 enhanced production to approximately 10% compared with the
parental Ac2F cells. However, neither mutant devoid of ZF2 or ZF1/2
enhanced luciferase at all. In cells expressing mutants devoid of RB1,
RB2, or RB1/2, luciferase activities decreased to a negligible level in
parental cells. Matrin 3 mutants in which there were neither NES nor
NLS including MRS did not augment luciferase activity.
Figure 3: Requirement of a domain in matrin 3 for the
augmentation of transcription. Lysates were prepared after 24 h
incubation of Ac2F cells expressing wild-type or Matrin 3 for the
transcriptional augmentation several type of deletion mutants of
matrin 3 transfected with pGL3 promoter or pGL3–Xmn I (left
panel) and luciferase activity was assayed (right panel).
Discussion
Our previous report described the principal properties of matrin 3
[3]. First, matrin 3 has several functionally confirmed motifs including
NLS, NES, ZF1, ZF2, RB1, RB2, and MRS. Second, matrin 3 is
localized not only in the nuclear scaffold but also in the soluble
fraction in the nucleus, and in the cytoplasmic, microsomal and
polysomal fractions of rat liver cells. Third, matrin 3 requires NLS and
NES for subcellular trafficking, and ZF1 and ZF2 for translocation
from soluble fraction to the nuclear scaffold fraction and therefore
enabling the chromosomal association of matrin 3.
Fourth, matrin 3 is a phosphorylated protein and its
phosphorylation status is altered in association with subcellular
trafficking. These properties can be considered as the molecular basis
of the diverse functions of matrin 3.
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We also reported that Xmn I or several MAR/SAR fragments whose
base unpairing appeared to play principal roles in binding to matrin 3,
when tethered upstream from the SV40 promoter increased reporter
luciferase gene transcription [7].
In the present study, we demonstrated that the Xmn I fragment as a
typical MAR/SAR augmented SV40 promoter-mediated luciferase
gene transcription determined by transiently expressed luciferase
activity (Figure 1). Furthermore, this segment in recombinant
plasmids, can interact with matrin 3, and the enhanced interaction of
Xmn I with overexpressed matrin 3 appeared to be required for
augmentation of luciferase gene transcription (Figures 1 and 2).
Furthermore, Figure 3 shows that all of the functional domains, not
only ZF1 and ZF2 for DNA binding but also RB1 and RB2 for RNA
binding, NLS and NES for subcellular trafficking, and MRS are
independently required for augmentation of gene transcription in
cells. In this context, the binding of matrin 3 to the Xmn I fragment
may result in conditions under which proteins required to form the
structural and functional basis of chromatins are more efficiently
assembled. Furthermore, domain structure-mediated subcellular
trafficking of matrin 3 may be involved in RNA metabolism in various
ways.
It has been reported that chromatin may have the potential to
change its configuration [10,11], as it is remodeled for transcription
regulation. SATB1 regulates transcription activity and recruits
chromatin-remodeling factors for region-specific histone modification
[12-16], SATB2 activates gamma-globin genes by binding to MARs in
their promoters and recruiting histone acetylase PCAF [17]. SAF-B
suppresses transcription activity through a recombinant promoter
constructs resembling the lysozyme 5` MAR promoter [18]. SMAR1,
which interacts with chromatin modulators including HDAC1, and
Sin3A causes chromatin condensation [19].
Histone deacetylase 1, a remodeling factor, interacts with the
nuclear matrix [20] and with ARBP, a MAR-binding protein [21]. The
expression of specific genes is enhanced by hnRNP-U by regulating
mRNA stability [22].
Matrin 3, an abundant protein of the internal nuclear matrix, has
been linked to a variety of functional events. Zeitz et al. have reported
that matrin 3 interacts with 33 unique nuclear localized proteins and
also revealed its propensity for self-association [23].
Recently, Skowronsk-Krqwczyk et al. reported that a homeodomain
transcription factor regulates gene transcriptional programs through
interaction with components of subnuclear structure such as the
matrin 3-rich network [24].
Zhang and Carmichael reported that human inosine-specific RNA
(I-RNA)-binidng protein p54nrb, a splicing factor PSF, and matrin 3
were co-purified from HeLa cells as a complex that binds hyperedited
RNA, supposedly for anchoring it to the nuclear matrix [25]. Recently,
it has been reported that matrin 3 that binds viral RNA is required for
the Rev/RRE mediated nuclear export of unspliced HIV-1 RNAs
[26-29], and it interacts in an RNA-dependent manner with several
proteins with established roles in RNA processing, and maintains its
interaction with RNA via its RNA recognition motif domain [30,31].
These data suggest that the cellular level of matrin 3, known to be
highly regulated, modulates the stability of a group of gene transcripts.
Animal and plant genomes carry MAR/SAR, which also interact
with the nuclear matrix. MAR/SAR segments are reportedly expected
to be present at both up and downstream boundaries of nuclear genes
[32] and are predicted to be distributed throughout the genome [33].
MAR/SAR positioned in the vicinity of a promoter can reportedly
augment transcription of a reporter gene, when the recombinant
construct is integrated into the genome of the host animal, suggesting
that MAR/SAR as cis-acting elements could boost the expression of
recombinant proteins from cultured cells. Given that gene transfer in
eukaryotic cells and organisms suffers from epigenetic effects that
result in low or unstable transgene expression and high clonal
variability, use of epigenetic regulators such as MAR/SAR is a
promising approach to alleviate such unwanted effects [34]. Thus this
study also suggests new strategies for the application of potent
epigenetic regulators, MAR/SAR with matrin 3 toward high and stable
transgene expression for research, therapeutic production, or gene-
based therapies.
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